Stryker (LTS:0R2S) Total Equity: $22,979 Mil (As of Mar. 2026)


LTS:0R2S Stryker Corp LTS:0R2S
89 GF Score
Price $325.22
GF Value $410.28
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Stryker Total Equity?

Stryker LTS:0R2S 89 Total Equity is $22,979 Mil as of Mar. 2026. GuruFocus rates LTS:0R2S with a GF Score™ of 89/100 and a GF Value™ of $410.28 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Stryker's total equity for the quarter that ended in Mar. 2026 was $22,979 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Stryker Total Equity Historical Data

* Premium members only.

The historical data trend for Stryker's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker Total Equity Chart

Stryker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,877.00 16,616.00 18,593.00 20,634.00 22,420.00

Stryker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20,930.00 21,191.00 21,785.00 22,420.00 22,979.00
LTS:0R2S
89GF Score
Stryker Corp LTS:0R2S
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stryker Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Stryker's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=47844-25424
=22,420

Stryker's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=46291-23312
=22,979

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $22,979 Mil mean?
Stryker (LTS:0R2S) has a Total Equity of $22,979 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Stryker and its competitors.
Is Stryker's Total Equity too high?
Stryker's current Total Equity is $22,979 Mil. Overall, Stryker has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's Total Equity compare to MDT and ABT?
Stryker's Total Equity of $22,979 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Stryker and its competitors. Stryker's current Total Equity is $22,979 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Modestly Undervalued. The stock's GF Value™ is $410.28, compared to a current price of $325.22 — trading 20.7% below its estimated fair value. The current Total Equity is $22,979 Mil. Stryker's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current Total Equity is $22,979 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stryker (LTS:0R2S) Overvalued in 2026?

Based on GuruFocus' analysis, Stryker stock appears to be undervalued. The current stock price of $325.22 is trading 20.7% below its estimated GF Value™ of $410.28. GuruFocus considers Stryker to be Modestly Undervalued.

Key valuation signals for LTS:0R2S:

  • Total Equity: $22,979 Mil
  • GF Value™: $410.28 vs. price of $325.22 (20.7% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stryker Business Description

Address 1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
89GF Score

Get the complete analysis for LTS:0R2S

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$325.22
Price
$410.28
GF Value